“…SERS spectroscopy has been used to detect molecules at low concentrations via signal enhancement by localized plasmon resonance in metal nanoparticles. − While SERS has offered strong potential to improve the detection sensitivity and temporal resolution in live-cell imaging, , the fluctuations of both signal intensity and peak position, which are due to high sensitivity to the interaction between molecules and the metal surface, have hindered practical use of SERS in biomedical applications. , In addition, SERS peaks of small molecules may also overlap with that of endogenous molecules at the Raman fingerprint region. However, the combination of SERS and alkyne-tag can solve this issue since the unique alkyne signal can be detected separately from Raman peaks from endogenous molecules. − In our technique, gold nanoparticles introduced in live cells work as agents to report the arrival of alkyne-tagged small-molecule drugs at lysosomes, where the nanoparticles also localize during the transport. − , Terminal alkynes show a high affinity to the surface of metals, such as silver and gold. − ,, Therefore, strong enhancement of the Raman signal from the alkyne can be expected due to chemical adsorption onto the surface of nanoparticles. We utilized an alkyne-tagged acyloxymethyl ketone type inhibitor (Alt-AOMK), an alkyne-tagged cathepsin B inhibitor, as a small-molecule drug.Three-dimensional SERS imaging was performed with home-built slit-scattering Raman microscopy, which achieves temporal resolution high enough to visualize drug uptake with the enhancement of the Raman signal.…”